Lupin Ltd Drug Patent Portfolio

Lupin Ltd's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Lupin Ltd News

Sun Pharma receives approval to market generic Wegovy in India - The HinduBusinessLine

23 Jan, 2026

Indian Pharmaceutical Sector Q3: Stable Revenue, Profit Decline Due to US Generic Drugs and Increasing Expenses

21 Jan, 2026

Upcoming expirations of GLP-1 drug patents attract generic manufacturers - C&EN

09 Dec, 2025

NCLAT rules that CCI is unable to investigate anti-competitive behavior related to patented medications - Bar and Bench

31 Oct, 2025

See More